边 霁，男，悉尼大学皇家北岸私立医院临床博士后、临床研究主管，国际肾病协会会员，澳大利亚糖尿病协会临床专家，澳大利亚新西兰肾病协会临床与研究专家，北京糖代谢研究会第二届理事会外籍理事。
教育背景
2020/10-2024/10 悉尼大学医学院 医学博士
博士课题: 慢性肾病临床创新治疗技术和方案研究
2013/07- 2015/06悉尼大学 硕士
专业: 生物医学工程 78.6%优秀毕业生
课题: 3-D 组织工程软组织和硬组织材料和应用研究
2003/09-2008/07 中国医科大学 临床本科
专业:临床和遗传学 85%优秀毕业生
课题: HQ-1基因突变在高血压家族谱系研究
眼药精准喷洒系统 (Ophthalmic drug delivery system), 同时在悉尼眼科医院实习半年 (Sydney Eye Hospital).
创新性低升糖指数固体饮料配方. 202010350074.3；19-11662CN Premium.
创新性低升糖指数面粉符合配方National Intellectual Properties Administration, PRC. 202010350194.3；19-11669CN
奖学金与研究基金
本科五年内连续奖学金获得者。硕士期间获得澳大利亚The Commonwealth Support Place scholarship in Sydney University during my master’s degree (Distinction).
2023年优秀博士生研究支持奖：PRSS (Postgraduate Research Support Scheme) 2022
2023 年优秀博士生研究支持奖：PRSS 2023
澳大利亚A类，澳大利亚联邦政府国家奖学金Research Training Program winner (Commonwealth government),2022
澳大利亚A类，澳大利亚联邦政府国家奖学金Research Training Program winner (Commonwealth government),2023
2022年SAN 临床研究基金创新基金：SAN Funding (Photobiomodulation clinical trials)2022
2022年澳大利亚境内参会基金：SSC National Travel Grant: 2022
2023年澳大利亚境内参会基金：SSC National travel grant: 2023
2022年澳大利亚境外参会基金：SSC International travel grant:2023
2022年美国肾病学会全球青年组”Kidney Star”获得者：American Society of Nephrology (ASN) 2023 Kidney Star Award
工作经历
德国柏林医学实验室北京中心医学主管2009/12～2012/06
中国医科大学心内科2007-2008
协会聘任
International Society of Nephrology (ISN)-国际肾病协会会员2021-2024
AUSTRALIA DIABETES SOCIETY MEMBERSHIP- SPECIALIST-CLINICIAN 澳大利亚糖尿病协会临床专家2018-2024
The Australian and New Zealand Society of Nephrology Scientist.澳大利亚新西兰肾病协会临床与研究专家2021-2024
研究成果国际会议
1.Photobiomodulation protects high-fat diet-induced diabetic kidney injury via inhibition of inflammation. Poster presentation. Kidney Week 2023 Philadelphia, PA, 02/11/2023-05/11/2023.
2.Photobiomodulation alleviates kidney damage in in vitro and Folic acid-induced kidney injury mouse model via suppressing inflammation and oxidative stress. Oral presentation. 58th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), 02/09/2023-06/09/2023.
3.Photobiomodulation alleviates chronic kidney disease via suppression of inflammation and oxidative stress. Oral presentation. 57th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), 17/10/2022-17/10/2022.
4.The Effects of Photobiomodulation on Chronic Kidney Disease. Poster presentation. ISN World Congress of Nephrology. Kuala Lumpur, Malaysia, 24/02/2022-27/02/2022.
5.The Potential Role of Photobiomodulation in an in-vitro Model of Chronic Kidney. Poster presentation. The international society for optics and photonics (SPIE), San Francisco, California, USA, 22–27 January 2022.
6.The role of Photobiomodulation (PBM) on chronic kidney disease (CKD). Oral presentation. Cardiovascular and Renal PRA’s Emerging Leaders Showcase. Kolling Institute of Medical Research| University of Sydney, Royal North Shore Hospital, St Leonards, Australia 8th October 2021.
7.Computational Modelling of Enamel Hierarchical Structure. Oral presentation. The Fourth Australasian Conference on Computational Mechanics University of Tasmania, Sandy Bay Campus | 28th–29th November 2019.
发表文章 [1-13]
1.Bian J, Huang C, Liebert A, Bicknell B, Chen X-M, Pollock C: The effect of photobiomodulation in an in vitro model on chronic kidney disease. In Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic and Photobiomodulation Therapy XXX. SPIE; 2022
2.Bian J, Liebert A, Bicknell B, Chen XM, Huang C, Pollock CA: Therapeutic Potential of Photobiomodulation for Chronic Kidney Disease. Int J Mol Sci 2022, 23:8043.
3.Bian J, Liebert A, Bicknell B, Chen XM, Huang C, Pollock CA: Faecal Microbiota Transplantation and Chronic Kidney Disease. Nutrients 2022, 14.
4.BIAN J, Pollock C, Huang C, Liebert A, Chen X: POS-360 The role of Photobiomodulation on chronic kidney disease. Kidney International Reports 2022, 7:S162-S163.
5.Dong Y, Wu X, Han L, Bian J, He C, El-Omar E, Gong L, Wang M: The Potential Roles of Dietary Anthocyanins in Inhibiting Vascular Endothelial Cell Senescence and Preventing Cardiovascular Diseases. Nutrients 2022, 14:2836.
6.Huang C, Bian J, Cao Q, Chen XM, Pollock CA: The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease. Int J Mol Sci 2021, 22.
7.Li K, Bian J, Xiao Y, Wang D, Han L, He C, Gong L, Wang M: Changes in Pancreatic Senescence Mediate Pancreatic Diseases. International Journal of Molecular Sciences 2023, 24:3513.
8.Li K, Xiao Y, Bian J, Han L, He C, El-Omar E, Gong L, Wang M: Ameliorative Effects of Gut Microbial Metabolite Urolithin A on Pancreatic Diseases. Nutrients 2022, 14.
9.Lu ZF, Jiang L, Lesani P, Zhang WJ, Li N, Luo D, Li Y, Ye Y, Bian J, Wang G, et al: Nicotinamide mononucleotide alleviates osteoblast senescence induction and promotes bone healing in osteoporotic mice. J Gerontol A Biol Sci Med Sci 2022.
10.Luo Z, Li M, Yang J, Li J, Zhang Y, Liu F, El-Omar E, Han L, Bian J, Gong L, Wang M: Ferulic acid attenuates high-fat diet-induced hypercholesterolemia by activating classic bile acid synthesis pathway. Frontiers in Nutrition 2022, 9.
11.Xiao Y, Li K, Bian J, Liu H, Zhai X, El-Omar E, Han L, Gong L, Wang M: Urolithin A Attenuates Diabetes-Associated Cognitive Impairment by Ameliorating Intestinal Barrier Dysfunction via N-glycan Biosynthesis Pathway. Mol Nutr Food Res 2022, 66:e2100863.
12.Zhang H, Li C, Han L, Xiao Y, Bian J, Liu C, Gong L, Liu Z, Wang M: MUP1 mediates urolithin A alleviation of chronic alcohol-related liver disease via gut-microbiota-liver axis. Gut Microbes 2024, 16:2367342.
13.Bian P, Liebert A, Huang H, Bicknell B, Pollock C: Photobiomodulation biphasic mechanisms in the treatment of renal fibrosis: evidence from in vitro and in vivo studies. In Mechanisms of Photobiomodulation Therapy XVIII. SPIE; 2024: PC1282608.
